Table 3.

Characteristics of patients prescribed first-line therapy (ART-AQ) or a co-prescription of antibiotics

	Anti-malarial prescribed				Antibiotic co-prescription
	ART-AQ		Other anti-malarial regimen		Antibiotic co-prescription		No antibiotic
	N = 1,217		N = 1,614		N = 872		N = 1,959
	n, %1		n, %		n, %		n, %
Gender
Male	464	40.9	672	59.2	376	33.1	760	66.9
Female	753	44.4	942	55.6	496	29.3	1,199	70.7
Age group
<5	161	26.4	449	73.6	260	42.6	350	57.4
5–12	181	56.9	136	43.1	119	37.4	198	62.5
13–59	790	46.0	926	54.0	445	25.9	1, 271	74.1
≥60	76	48.4	81	51.6	40	25.5	117	74.5
Not known	9	29.0	22	71.0	8	25.8	23	74.2
Facility type
Non-government	15	13.0	100	87.0	28	24.4	87	75.7
Government	1,202	44.3	1,514	55.7	844	31.1	1,872	68.9
Mode of diagnosis
Presumptive	1,041	42.2	1,427	57.8	758	30.7	1,710	69.3
Laboratory confirmed	79	86.8	12	13.2	21	23.1	70	76.9
Not known	97	35.7	175	64.3	93	34.2	179	65.8
Anti-malarial treatment prescribed
Combination therapy (ART-AQ)	-		-		349	28.7	868	71.3
Combination therapy (Other ACT)	-		-		140	33.5	278	66.5
Monotherapy (Artemisinin based)	-		-		277	29.6	659	70.4
Monotherapy (Non-artemisinin)	-		-		106	40.8	154	59.2

¹ % are row percentages within supercolumns